January 29, 2020
TB Alliance Partners with ERA4TB, an International Consortium to Accelerate the Development of Comprehensive Treatments against Tuberculosis
More than 30 partners from 13 countries participate in the ERA4TB project January 27, 2020
New Research Assesses Efficacy of Different Doses of Linezolid, Key Medicine Used in Regimens that Treat Drug-Resistant Tuberculosis
January 16, 2020
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant Forms of TB in China
Non-profit drug developer partners with leading manufacturer of tuberculosis medicine in China November 13, 2019
Results of Phase 2B Clinical Trial Testing New Drug-Resistant TB Treatment Published in Lancet Respiratory Medicine
November 6, 2019
Global Health Innovators Come Together to Identify Ways to Further Strengthen European Investment in Global Health Research & Innovation
October 28, 2019
TB Alliance and Macleods Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB
Non-profit product development partnership and generic manufacturer agree to produce new TB drug for countries with high incidence of TB October 17, 2019
With One and a Half Million People Dying from TB Every Year, It’s Time to Accelerate Progress
Statement from TB Alliance on WHO Global TB Report 2019 September 23, 2019
TB Alliance Statement on TB REACH Wave 7
A Welcome Investment in TB Treatment August 14, 2019